Free Float 28,93 %
Shares Float 63,56 M
Shares Outstanding 219,7 M
Dali Pharmaceuticalco.,Ltd
Share · CNE100002VL4 (XSHG)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Dali Pharmaceuticalco.,Ltd
No Price
Share Float & Liquidity
Company Profile for Dali Pharmaceuticalco.,Ltd Share
Dali Pharmaceuticalco.,Ltd researches, develops, produces, and sells pharmaceutical products in China. It develops Chinese and Western medicine injection products of 20 varieties with 44 specifications of the injection drug approval number. The company's products include xingnaojing, shenmai, and astragalus injections, as well as leucocin A and citicoline injections. It also has 31 patents, including 11 invention patents, 16 utility models, and 3 design patents. The company was founded in 1996 and is headquartered in Dali, China.
Company Data
Name Dali Pharmaceuticalco.,Ltd
Company Dali Pharmaceuticalco.,Ltd
Website
https://www.daliyaoye.cn
Primary Exchange 
SSE
SSE
ISIN CNE100002VL4
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Jun Xiang Yang
Market Capitalization 259 Mio
Country China
Currency CNY
Employees 0,3 T
Address No. 118, West Huancheng Road, 671000 Dali
IPO Date 2017-09-22
Dividends from 'Dali Pharmaceuticalco.,Ltd'
| Ex-Date | Dividend per Share |
|---|---|
| 23.06.2021 | 0,05 CNY |
| 10.06.2019 | 0,10 CNY |
| 05.07.2018 | 0,10 CNY |
Stock Splits
| Date | Split |
|---|---|
| 08.06.2020 | 13:10 |
| 10.06.2019 | 13:10 |
| 05.07.2018 | 13:10 |
Ticker Symbols
| Name | Symbol |
|---|---|
| SSE | 603963.SS |
More Shares
Investors who hold Dali Pharmaceuticalco.,Ltd also have the following shares in their portfolio:
